Please login to the form below
Corlaner
This page shows the latest Corlaner news and features for those working in and with pharma, biotech and healthcare.
Amgen takes aim at cardio diseases with Arrowhead RNAi deal
Amgen is a recent entrant into the cardiovascular drugs arena, with recently-approved cholesterol-lowering drug Repatha (evolocumab) and heart failure drug Corlaner (ivabradine) spearheading its assault on the market.
Latest news
-
Amgen starts shipping Corlaner in US
Firm also reports healthy financial growth in the first quarter. . Amgen has started shipping its Corlaner heart failure therapy to wholesalers in the US just a few days after getting FDA ... Corlaner (ivabradine) - the first new medicine for chronic
-
FDA clears Amgen's Corlaner for heart failure
The FDA approved Corlaner (ivabradine) after a priority review for reducing the risk of hospitalisation for worsening heart failure in patients with stable, symptomatic chronic heart failure (CHF). . ... Corlaner's approval is based on the results of
-
Amgen banking on three launches in 2015
year. These are evolocumab for high cholesterol, heart failure drug Corlaner (ivabradine) and talimogene laherparepvec (T-VEC) for melanoma. ... Despite the upbeat comments, Amgen did reveal that Corlaner and T-VEC have both been delayed by requests for
More from news
Approximately 2 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
Heart failure therapy embarks on a new era
Corlaner costs around the same as Entresto at around $4, 500 per year. ... Entresto and Corlaner are expected to account for the bulk of that increase, with Entresto taking the lion's share.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Client Services Director- Flexible Working
-
Negotiable
-
Events Executive
-
DOE
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director – UK Office
-
Excellent salary and benefits
-
Senior Medical Writer
-
Competitive salary plus benefits
- Account Manager – Healthcare advertising
-
Salary TBC
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- AZ, Merck’s Lynparza scores market-expanding clinical success
- AbbVie/Allergan's merger faces public opposition
- How can we realise the benefits of patient engagement?
- Half of European cancer drug trials ‘biased’, says BMJ
- Four Health and ARK among winners at PM Society Digital Awards
- Democrats’ final pricing plan announced, 250 drugs targeted
- Insys gets bankruptcy court okay for Subsys sale
- Breath test could predict response to immunotherapy
PMHub
Anthill Agency
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
